Product Information
PHENTERMINE 8 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.6181 per EA under NDC 62135095990. Its NADAC has been published 41 times since Dec 24, 2025.
FDA first approved this application before 1982.
The High Outlier badge above means this manufacturer's average price in the Phentermine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
8 mg/1
Manufacturer
Chartwell RX LLCNDC
62135095990
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA083923FDA Approved
Before 1982
On Market Since
7/1/1976
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 8 MG TABLET has been published 41 times since Dec 24, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6181 per EA |
|---|---|
| All-time high | $0.6181 (Sep 30, 2026) |
| All-time low | $0.6144 (Dec 24, 2025) |
| 52-week high | $0.6181 |
| 52-week low | $0.6144 |
| Median price | $0.6147 |
| Average price | $0.6151 |
| Largest weekly change | +0.4% (Sep 23, 2026) |
| Weeks tracked | 41 |
| Tracking since | Dec 24, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phentermine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sympathomimetic Amine Anorectic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENTERMINE 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 8 MG TABLET, manufactured by Chartwell RX LLC, is $0.6181 per EA (NDC 62135095990), effective Sep 30, 2026.
How has the price of PHENTERMINE 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 8 MG TABLET has held within roughly two percent of its current level. It has been tracked across 41 weekly CMS publications since Dec 24, 2025.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 8 MG TABLET?
Since Dec 24, 2025, the NADAC for PHENTERMINE 8 MG TABLET has ranged from a low of $0.6144 (Dec 24, 2025) to a high of $0.6181 (Sep 30, 2026), with a median of $0.6147 per EA.
Are there cheaper alternatives to PHENTERMINE 8 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PHENTERMINE 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PHENTERMINE 8 MG TABLET?
PHENTERMINE 8 MG TABLET (NDC 62135095990) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.